Cargando…

White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control Disorders

Impulse control disorders (ICDs) are relatively frequent in patients with Parkinson’s disease (PD), although it is still unclear whether an underlying pathological process plays a significant role in the development of ICD in PD apart from dopaminergic replacement therapy. In this study, we have inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Mojtahed Zadeh, Mahtab, Ashraf-Ganjouei, Amir, Ghazi Sherbaf, Farzaneh, Haghshomar, Maryam, Aarabi, Mohammad Hadi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890183/
https://www.ncbi.nlm.nih.gov/pubmed/29662464
http://dx.doi.org/10.3389/fneur.2018.00163
_version_ 1783312821434449920
author Mojtahed Zadeh, Mahtab
Ashraf-Ganjouei, Amir
Ghazi Sherbaf, Farzaneh
Haghshomar, Maryam
Aarabi, Mohammad Hadi
author_facet Mojtahed Zadeh, Mahtab
Ashraf-Ganjouei, Amir
Ghazi Sherbaf, Farzaneh
Haghshomar, Maryam
Aarabi, Mohammad Hadi
author_sort Mojtahed Zadeh, Mahtab
collection PubMed
description Impulse control disorders (ICDs) are relatively frequent in patients with Parkinson’s disease (PD), although it is still unclear whether an underlying pathological process plays a significant role in the development of ICD in PD apart from dopaminergic replacement therapy. In this study, we have investigated alterations of white matter tract in drug-naïve PD patients with ICDs via diffusion MRI connectometry. Our results showed that disrupted connectivity in the complex network of dynamic connections between cerebellum, basal ganglia, cortex, and its spinal projections serves as the underlying neuropathology of ICD in PD not interfered with the contribution of dopaminergic replacement therapy. These findings provide the first evidence on involved white matter tracts in the neuropathogenesis of ICD in drug-naïve PD population, supporting the hypothesis that neural disturbances intrinsic to PD may confer an increased risk for ICDs. Future studies are needed to validate the attribution of the impaired corticocerebellar network to impulsivity in PD.
format Online
Article
Text
id pubmed-5890183
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-58901832018-04-16 White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control Disorders Mojtahed Zadeh, Mahtab Ashraf-Ganjouei, Amir Ghazi Sherbaf, Farzaneh Haghshomar, Maryam Aarabi, Mohammad Hadi Front Neurol Neuroscience Impulse control disorders (ICDs) are relatively frequent in patients with Parkinson’s disease (PD), although it is still unclear whether an underlying pathological process plays a significant role in the development of ICD in PD apart from dopaminergic replacement therapy. In this study, we have investigated alterations of white matter tract in drug-naïve PD patients with ICDs via diffusion MRI connectometry. Our results showed that disrupted connectivity in the complex network of dynamic connections between cerebellum, basal ganglia, cortex, and its spinal projections serves as the underlying neuropathology of ICD in PD not interfered with the contribution of dopaminergic replacement therapy. These findings provide the first evidence on involved white matter tracts in the neuropathogenesis of ICD in drug-naïve PD population, supporting the hypothesis that neural disturbances intrinsic to PD may confer an increased risk for ICDs. Future studies are needed to validate the attribution of the impaired corticocerebellar network to impulsivity in PD. Frontiers Media S.A. 2018-03-20 /pmc/articles/PMC5890183/ /pubmed/29662464 http://dx.doi.org/10.3389/fneur.2018.00163 Text en Copyright © 2018 Mojtahed Zadeh, Ashraf-Ganjouei, Ghazi Sherbaf, Haghshomar and Aarabi. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Mojtahed Zadeh, Mahtab
Ashraf-Ganjouei, Amir
Ghazi Sherbaf, Farzaneh
Haghshomar, Maryam
Aarabi, Mohammad Hadi
White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control Disorders
title White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control Disorders
title_full White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control Disorders
title_fullStr White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control Disorders
title_full_unstemmed White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control Disorders
title_short White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control Disorders
title_sort white matter tract alterations in drug-naïve parkinson’s disease patients with impulse control disorders
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5890183/
https://www.ncbi.nlm.nih.gov/pubmed/29662464
http://dx.doi.org/10.3389/fneur.2018.00163
work_keys_str_mv AT mojtahedzadehmahtab whitemattertractalterationsindrugnaiveparkinsonsdiseasepatientswithimpulsecontroldisorders
AT ashrafganjoueiamir whitemattertractalterationsindrugnaiveparkinsonsdiseasepatientswithimpulsecontroldisorders
AT ghazisherbaffarzaneh whitemattertractalterationsindrugnaiveparkinsonsdiseasepatientswithimpulsecontroldisorders
AT haghshomarmaryam whitemattertractalterationsindrugnaiveparkinsonsdiseasepatientswithimpulsecontroldisorders
AT aarabimohammadhadi whitemattertractalterationsindrugnaiveparkinsonsdiseasepatientswithimpulsecontroldisorders